CoreCap Advisors’s Novartis NVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221K | Buy |
1,825
+475
| +35% | +$57.5K | 0.01% | 712 |
|
|
2025
Q1 | $150K | Sell |
1,350
-729
| -35% | -$81.3K | 0.01% | 758 |
|
|
2024
Q4 | $202K | Buy |
2,079
+523
| +34% | +$50.9K | 0.01% | 703 |
|
|
2024
Q3 | $179K | Buy |
1,556
+1,162
| +295% | +$134K | 0.01% | 729 |
|
|
2024
Q2 | $41.9K | Buy |
394
+24
| +6% | +$2.56K | ﹤0.01% | 704 |
|
|
2024
Q1 | $35.8K | Buy |
+370
| New | +$35.8K | ﹤0.01% | 1249 |
|
|
2022
Q4 | $36.8K | Buy |
+406
| New | +$36.8K | ﹤0.01% | 1096 |
|
|
2022
Q3 | – | Sell |
-1,502
| Closed | -$127K | – | 1555 |
|
|
2022
Q2 | $127K | Buy |
+1,502
| New | +$127K | 0.01% | 617 |
|
|
2022
Q1 | – | Sell |
-2,038
| Closed | -$178K | – | 1549 |
|
|
2021
Q4 | $178K | Buy |
+2,038
| New | +$178K | 0.01% | 559 |
|